87 related articles for article (PubMed ID: 7491907)
1. Endothall thioanhydride inhibits protein phosphatases-1 and -2A in vivo.
Erdödi F; Tóth B; Hirano K; Hirano M; Hartshorne DJ; Gergely P
Am J Physiol; 1995 Nov; 269(5 Pt 1):C1176-84. PubMed ID: 7491907
[TBL] [Abstract][Full Text] [Related]
2. Protein phosphatase 2A and its [3H]cantharidin/[3H]endothall thioanhydride binding site. Inhibitor specificity of cantharidin and ATP analogues.
Li YM; Mackintosh C; Casida JE
Biochem Pharmacol; 1993 Oct; 46(8):1435-43. PubMed ID: 8240393
[TBL] [Abstract][Full Text] [Related]
3. Cantharidin-binding protein: identification as protein phosphatase 2A.
Li YM; Casida JE
Proc Natl Acad Sci U S A; 1992 Dec; 89(24):11867-70. PubMed ID: 1334551
[TBL] [Abstract][Full Text] [Related]
4. Endothall thioanhydride: structural aspects of unusually high mouse toxicity and specific binding site in liver.
Kawamura N; Li YM; Engel JL; Dauben WG; Casida JE
Chem Res Toxicol; 1990; 3(4):318-24. PubMed ID: 2133079
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular carcinoma cell lines from diethylnitrosamine phenobarbital-treated rats. Characterization and sensitivity to endothall, a protein serine/threonine phosphatase-2A inhibitor.
Thièry JP; Blazsek I; Legras S; Marion S; Reynes M; Anjo A; Adam R; Misset JL
Hepatology; 1999 May; 29(5):1406-17. PubMed ID: 10216123
[TBL] [Abstract][Full Text] [Related]
6. On the cardiac contractile, electrophysiological and biochemical effects of endothall, a protein phosphatase inhibitor.
Bokník P; Vahlensieck U; Huke S; Knapp J; Linck B; Lüss H; Müller FU; Neumann J; Schmitz W
Pharmacology; 2000 Jul; 61(1):43-50. PubMed ID: 10895080
[TBL] [Abstract][Full Text] [Related]
7. Contractility and inhibition of protein phosphatases by cantharidin.
Knapp J; Bokník P; Huke S; Gombosová I; Linck B; Lüss H; Müller FU; Müller T; Nacke P; Schmitz W; Vahlensieck U; Neumann J
Gen Pharmacol; 1998 Nov; 31(5):729-33. PubMed ID: 9809469
[TBL] [Abstract][Full Text] [Related]
8. Cantharimides: a new class of modified cantharidin analogues inhibiting protein phosphatases 1 and 2A.
McCluskey A; Walkom C; Bowyer MC; Ackland SP; Gardiner E; Sakoff JA
Bioorg Med Chem Lett; 2001 Nov; 11(22):2941-6. PubMed ID: 11677131
[TBL] [Abstract][Full Text] [Related]
9. Cantharidin, another natural toxin that inhibits the activity of serine/threonine protein phosphatases types 1 and 2A.
Honkanen RE
FEBS Lett; 1993 Sep; 330(3):283-6. PubMed ID: 8397101
[TBL] [Abstract][Full Text] [Related]
10. Cantharidin enhances norepinephrine-induced vasoconstriction in an endothelium-dependent fashion.
Knapp J; Bokník P; Linck B; Lüss H; Müller FU; Petertönjes L; Schmitz W; Neumann J
J Pharmacol Exp Ther; 2000 Aug; 294(2):620-6. PubMed ID: 10900240
[TBL] [Abstract][Full Text] [Related]
11. Anticancer activity and protein phosphatase 1 and 2A inhibition of a new generation of cantharidin analogues.
Sakoff JA; Ackland SP; Baldwin ML; Keane MA; McCluskey A
Invest New Drugs; 2002 Feb; 20(1):1-11. PubMed ID: 12003183
[TBL] [Abstract][Full Text] [Related]
12. Protein phosphatase in neuroblastoma cells: [3H]cantharidin binding site in relation to cytotoxicity.
Laidley CW; Cohen E; Casida JE
J Pharmacol Exp Ther; 1997 Mar; 280(3):1152-8. PubMed ID: 9067298
[TBL] [Abstract][Full Text] [Related]
13. Calcium-independent activation of the contractile apparatus in smooth muscle of mouse aorta by protein phosphatase inhibition.
Knapp J; Aleth S; Balzer F; Schmitz W; Neumann J
Naunyn Schmiedebergs Arch Pharmacol; 2002 Dec; 366(6):562-9. PubMed ID: 12444498
[TBL] [Abstract][Full Text] [Related]
14. The inhibition of protein phosphatases 1 and 2A: a new target for rational anti-cancer drug design?
McCluskey A; Ackland SP; Gardiner E; Walkom CC; Sakoff JA
Anticancer Drug Des; 2001 Dec; 16(6):291-303. PubMed ID: 12375882
[TBL] [Abstract][Full Text] [Related]
15. Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A.
Cirak Y; Varol U; Atmaca H; Kisim A; Sezgin C; Karabulut B; Uzunoglu S; Uslu R; Karaca B
BJU Int; 2012 Dec; 110(11 Pt C):E1147-54. PubMed ID: 22882676
[TBL] [Abstract][Full Text] [Related]
16. Cantharidin analogues: synthesis and evaluation of growth inhibition in a panel of selected tumour cell lines.
McCluskey A; Ackland SP; Bowyer MC; Baldwin ML; Garner J; Walkom CC; Sakoff JA
Bioorg Chem; 2003 Feb; 31(1):68-79. PubMed ID: 12697169
[TBL] [Abstract][Full Text] [Related]
17. Protein phosphatase 2A plays a critical role in interleukin-2-induced beta 2-integrin dependent homotypic adhesion in human CD4+ T cell lines.
Brockdorff J; Nielsen M; Svejgaard A; Dobson P; Röpke C; Geisler C; Odum N
Cytokine; 1997 May; 9(5):333-9. PubMed ID: 9195132
[TBL] [Abstract][Full Text] [Related]
18. Heterocyclic substituted cantharidin and norcantharidin analogues--synthesis, protein phosphatase (1 and 2A) inhibition, and anti-cancer activity.
Hill TA; Stewart SG; Sauer B; Gilbert J; Ackland SP; Sakoff JA; McCluskey A
Bioorg Med Chem Lett; 2007 Jun; 17(12):3392-7. PubMed ID: 17451951
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of serine/threonine-specific protein phosphatases causes premature activation of cdc2MsF kinase at G2/M transition and early mitotic microtubule organisation in alfalfa.
Ayaydin F; Vissi E; Mészáros T; Miskolczi P; Kovács I; Fehér A; Dombrádi V; Erdödi F; Gergely P; Dudits D
Plant J; 2000 Jul; 23(1):85-96. PubMed ID: 10929104
[TBL] [Abstract][Full Text] [Related]
20. Anhydride modified cantharidin analogues: synthesis, inhibition of protein phosphatases 1 and 2A and anticancer activity.
McCluskey A; Bowyer MC; Collins E; Sim ATR ; Sakoff JA; Baldwin ML
Bioorg Med Chem Lett; 2000 Aug; 10(15):1687-90. PubMed ID: 10937725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]